Yahoo! Finance: COX.PA NewsCopyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=cox.paLatest Financial News for NICOXen-usTue, 22 Dec 2009 06:08:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifYahoo! Financehttp://finance.yahoo.com14417NicOx submits naproxcinod MAA to the EMEA (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091222/0571718.html?.v=1yahoo_finance/3162917441Tue, 22 Dec 2009 06:08:00 Etc/GMTNicOx announces FDA accepts naproxcinod NDA for filing (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091118/0560547.html?.v=1yahoo_finance/2883895653Wed, 18 Nov 2009 06:47:00 Etc/GMTNicOx announces NCX 6560 meets primary and secondary objectives in first-in- man study (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091113/0558859.html?.v=1yahoo_finance/4200623389Fri, 13 Nov 2009 06:06:00 Etc/GMTQ3 2009 NicOx Earnings Release - 01:00 am ET (CCBN)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091022.html?t=cox.payahoo_finance/2869894573Thu, 22 Oct 2009 11:07:21 Etc/GMTReport of NicOx's financial results for the first three quarters of 2009 (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091022/0550385.html?.v=1yahoo_finance/2212074044Thu, 22 Oct 2009 05:10:00 Etc/GMTNicOx presents 26 week naproxcinod efficacy data at American College of Rheumatology (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091020/0549234.html?.v=1yahoo_finance/1280929469Tue, 20 Oct 2009 05:08:00 Etc/GMTNicOx submits New Drug Application (NDA) for naproxcinod to the US FDA (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090925/0540948.html?.v=1yahoo_finance/1383636543Fri, 25 Sep 2009 05:09:00 Etc/GMTImportant data for NicOx' naproxcinod published in the American Journal of Cardiology (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090922/0539543.html?.v=1yahoo_finance/3372205439Tue, 22 Sep 2009 05:00:00 Etc/GMTNicOx makes three scientific presentations at the 2009 World Congress on Osteoarthritis (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090914/0536569.html?.v=1yahoo_finance/1704639869Mon, 14 Sep 2009 05:00:00 Etc/GMTNicOx reacquires rights to PF-03187207 for glaucoma from Pfizer (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090806/0525401.html?.v=2yahoo_finance/3149926941Thu, 6 Aug 2009 05:05:00 Etc/GMTNicOx first half 2009 financial results: naproxcinod nearing regulatory submissions in US and Europe (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090729/0522993.html?.v=1yahoo_finance/4097661709Wed, 29 Jul 2009 05:17:00 Etc/GMTNicOx: additional 24 hour blood pressure results for naproxcinod presented at the European Meeting on Hypertension (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090615/0510495.html?.v=2yahoo_finance/3979144124Mon, 15 Jun 2009 05:05:00 Etc/GMTNicOx presents naproxcinod results in several posters at EULAR (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090612/0510116.html?.v=2yahoo_finance/4088686577Fri, 12 Jun 2009 05:00:00 Etc/GMTNicOx publishes results of the ZEST phase 2 study for naproxcinod (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090609/0508888.html?.v=2yahoo_finance/1739894408Tue, 9 Jun 2009 05:00:00 Etc/GMTNicOx presents phase 3 quality of life data for naproxcinod at ISPOR (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090519/0502565.html?.v=3yahoo_finance/2778676757Tue, 19 May 2009 05:07:00 Etc/GMTNicOx reports first quarter 2009 financial results (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090513/0500723.html?.v=2yahoo_finance/1931672020Wed, 13 May 2009 05:14:00 Etc/GMTAnalyses of phase 3 blood pressure data for NicOx' naproxcinod presented at ASH (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090507/0498825.html?.v=2yahoo_finance/3070566896Thu, 7 May 2009 05:08:00 Etc/GMTAnalyses of phase 3 blood pressure data for NicOx' naproxcinod presented at ASH (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090507/0498825.html?.v=3yahoo_finance/3070566897Thu, 7 May 2009 05:08:00 Etc/GMTNicOx co-presents four posters on PF 03187207 for glaucoma at ARVO with Pfizer Inc (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090505/0497778.html?.v=2yahoo_finance/804837826Tue, 5 May 2009 05:05:00 Etc/GMTNicOx acquires Nitromed's NO-donating patents (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090423/0494030.html?.v=1yahoo_finance/3431324494Thu, 23 Apr 2009 05:00:00 Etc/GMT